Inhibition of platelet activation suppresses reactive enteric glia and mitigates intestinal barrier dysfunction during sepsis
Abstract Background Intestinal barrier dysfunction, which is associated with reactive enteric glia cells (EGCs), is not only a result of early sepsis but also a cause of multiple organ dysfunction syndrome. Inhibition of platelet activation has been proposed as a potential treatment for septic patie...
Main Authors: | Bo Cheng, Mengyu Du, Shuxuan He, Lan Yang, Xi Wang, Hui Gao, Haiqing Chang, Wei Gao, Yan Li, Qiang Wang, Yansong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10020-022-00556-8 |
Similar Items
-
CD40–CD40L in Neurological Disease
by: Heather D. Ots, et al.
Published: (2022-04-01) -
Reduced Relapse-Free Survival in Colorectal Cancer Patients with Elevated Soluble CD40 Ligand Levels Improved by Vitamin D Supplementation
by: Hiroshi Fujimoto, et al.
Published: (2023-10-01) -
RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse
by: Yizhi Chen, et al.
Published: (2023-06-01) -
CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
by: Steffen Daub, et al.
Published: (2020-11-01) -
Immunological Reactivity and Intensity of Oxidative Stress in Stable Coronary Artery Disease
by: Tetiana І. Gavrilenko, et al.
Published: (2023-09-01)